Showing results (861-870 of 1,402) with videos related to

Sort By:
Pageof 141
Pharmacology Research & Perspectives|December 16, 2014
Differential analysis of transient increases of serum cTnI in response to handling in ratsIgor Mikaelian, Michael E Dunn, Diane R Mould, et al.
Pharmacology Research & Perspectives|December 16, 2014
In vitro metabolism and metabolic effects of ajulemic acid, a synthetic cannabinoid agonistSumner H Burstein, Mark A Tepper
Pharmacology Research & Perspectives|December 16, 2014
Antagonism of human CC-chemokine receptor 4 can be achieved through three distinct binding sites on the receptorRobert J Slack, Linda J Russell, Nick P Barton, et al.
Pharmacology Research & Perspectives|December 16, 2014
Nigramide J is a novel potent inverse agonist of the human constitutive androstane receptorYuichiro Kanno, Nobuaki Tanuma, Tomofumi Yatsu, et al.
Pharmacology Research & Perspectives|December 16, 2014
From the dual function lead AP2238 to AP2469, a multi-target-directed ligand for the treatment of Alzheimer's diseaseAndrea Tarozzi, Manuela Bartolini, Lorna Piazzi, et al.
Pharmacology Research & Perspectives|December 16, 2014
Species differences in sinusoidal and canalicular efflux transport of mycophenolic acid 7-O-glucuronide in sandwich-cultured hepatocytesKazuhiro Tetsuka, Nicolas Gerst, Kouichi Tamura, et al.
Pharmacology Research & Perspectives|December 16, 2014
Discrepancies in listed adverse drug reactions in pharmaceutical product information supplied by the regulatory authorities in Denmark and the USARobert Eriksson, Lise Aagaard, Lars Juhl Jensen, et al.
Pharmacology Research & Perspectives|December 16, 2014
Hydroxyethyl starch as an effective methotrexate carrier in anticancer therapyT M Goszczyński, B Filip-Psurska, K Kempińska, et al.
Pharmacology Research & Perspectives|December 16, 2014
The in vivo efficacy and side effect pharmacology of GS-5759, a novel bifunctional phosphodiesterase 4 inhibitor and long-acting β 2-adrenoceptor agonist in preclinical animal speciesMichael Salmon, Stacey L Tannheimer, Terry T Gentzler, et al.
Pharmacology Research & Perspectives|December 16, 2014
Methyllycaconitine- and scopolamine-induced cognitive dysfunction: differential reversal effect by cognition-enhancing drugsEmile Andriambeloson, Bertrand Huyard, Etienne Poiraud, et al.
Pageof 141